Thromb Res. 1991 Jul 1;63(1):133-43.

Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement.

Source

Krankenhaus Bethanien, Dortmund, Germany.

Abstract

In 110 high-risk patients undergoing total hip replacement the antithrombotic efficacy and safety of a single daily injection of 1500 aPTT-U low-molecular-weight heparin plus 0.5 mg dihydroergotamine (Embolex) was, in a double-blind study, compared with a twice daily administration of 5000 IU of the heparin-dihydroergotamine combination Heparin-Dihydergot. Deep vein thrombosis diagnosed with phlebography occurred in 9.6% in the Embolex-group and in 25% in the Heparin-Dihydergot-group. Intra- and postoperative blood loss and blood replacement were similar in both groups. Therefore, and on account of the single daily administration, Embolex offers at least the advantage of improved compliance of the patients and reduced workload of the nursing staff.

PMID:: 1658962; [PubMed - indexed for MEDLINE]

Supplemental Content

Save items

Related citations in PubMed

Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine. [Arzneimittelforschung. 1987]
Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
Haas S, Stemberger A, Fritsche HM, Welzel D, Wolf H, Lechner F, Blümel G. Arzneimittelforschung. 1987 Jul; 37(7):839-43.
A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. [Thromb Haemost. 1996]
A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H. Thromb Haemost. 1996 Feb; 75(2):246-50.
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery. [Br J Surg. 1988]
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
Lassen MR, Borris LC, Christiansen HM, Møller-Larsen F, Knudsen VE, Boris P, Nehen AM, de Carvalho A, Jurik AG, Nielsen BW. Br J Surg. 1988 Jul; 75(7):686-9.
Review Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. [Arch Intern Med. 2001]
Review Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, et al. Arch Intern Med. 2001 Sep 10; 161(16):1952-60.
Review [Low molecular heparin in prevention of thrombosis in orthopedic surgery]. [Ugeskr Laeger. 1993]
Review [Low molecular heparin in prevention of thrombosis in orthopedic surgery].
Jensen HP, Borris LC, Lassen MR, Sørensen JV, Rahr HB, Christiansen HM, Ejstrud P. Ugeskr Laeger. 1993 Apr 12; 155(15):1109-15.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroer...
Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement.
Thromb Res. 1991 Jul 1 ;63(1):133-43.

PubMed
THE EFFECT OF DIABETES AND FASTING ON LIVER GLUCOSE-6-PHOSPHATASE.
THE EFFECT OF DIABETES AND FASTING ON LIVER GLUCOSE-6-PHOSPHATASE.
Proc Natl Acad Sci U S A. 1954 Aug ;40(8):673-8.

PubMed
Neuroleptics in painful thiamine deficiency neuropathy.
Neuroleptics in painful thiamine deficiency neuropathy.
South Med J. 1991 Nov ;84(11):1362-3.

PubMed
Genomic structure of the human prototype strain H of hepatitis C virus: comparis...
Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.
Proc Natl Acad Sci U S A. 1991 Nov 15 ;88(22):10292-6.

PubMed
Does superoxide underlie the pathogenesis of hypertension?
Does superoxide underlie the pathogenesis of hypertension?
Proc Natl Acad Sci U S A. 1991 Nov 15 ;88(22):10045-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information